-
BrainPainter v2: Mouse Brain Visualization Software
Authors:
Vedvayas Mallela,
Polina Golland,
Razvan V. Marinescu
Abstract:
BrainPainter is a software for the 3D visualization of human brain structures; it generates colored brain images using user-defined biomarker data for each brain region. However, BrainPainter is only able to generate human brain images. In this paper, we present updates to the existing BrainPainter software which enables the generation of mouse brain images. We load meshes for each mouse brain reg…
▽ More
BrainPainter is a software for the 3D visualization of human brain structures; it generates colored brain images using user-defined biomarker data for each brain region. However, BrainPainter is only able to generate human brain images. In this paper, we present updates to the existing BrainPainter software which enables the generation of mouse brain images. We load meshes for each mouse brain region, based on the Allen Mouse Brain Atlas, into Blender, a powerful 3D computer graphics engine. We then use Blender to color each region and generate images of subcortical, outer-cortical, inner-cortical, top and bottom view renders. In addition to those views, we add new render angles and separate visualization settings for the left and right hemispheres. While BrainPainter traditionally ran from the browser ( https://brainpainter.csail.mit.edu ), we also created a graphical user interface that launches image-generation requests in a user-friendly way, by connecting to the Blender backend via a Docker API. We illustrate a use case of BrainPainter for modeling the progression of tau protein accumulation in a mouse study. Our contributions can help neuroscientists visualize brains in mouse studies and show disease progression. In addition, integration into Blender can subsequently enable the generation of complex animations using a moving camera, generation of complex mesh deformations that simulate tumors and other pathologies, as well as visualization of toxic proteins using Blender's particle system.
△ Less
Submitted 24 March, 2021;
originally announced March 2021.
-
Bayesian Image Reconstruction using Deep Generative Models
Authors:
Razvan V Marinescu,
Daniel Moyer,
Polina Golland
Abstract:
Machine learning models are commonly trained end-to-end and in a supervised setting, using paired (input, output) data. Examples include recent super-resolution methods that train on pairs of (low-resolution, high-resolution) images. However, these end-to-end approaches require re-training every time there is a distribution shift in the inputs (e.g., night images vs daylight) or relevant latent va…
▽ More
Machine learning models are commonly trained end-to-end and in a supervised setting, using paired (input, output) data. Examples include recent super-resolution methods that train on pairs of (low-resolution, high-resolution) images. However, these end-to-end approaches require re-training every time there is a distribution shift in the inputs (e.g., night images vs daylight) or relevant latent variables (e.g., camera blur or hand motion). In this work, we leverage state-of-the-art (SOTA) generative models (here StyleGAN2) for building powerful image priors, which enable application of Bayes' theorem for many downstream reconstruction tasks. Our method, Bayesian Reconstruction through Generative Models (BRGM), uses a single pre-trained generator model to solve different image restoration tasks, i.e., super-resolution and in-painting, by combining it with different forward corruption models. We keep the weights of the generator model fixed, and reconstruct the image by estimating the Bayesian maximum a-posteriori (MAP) estimate over the input latent vector that generated the reconstructed image. We further use variational inference to approximate the posterior distribution over the latent vectors, from which we sample multiple solutions. We demonstrate BRGM on three large and diverse datasets: (i) 60,000 images from the Flick Faces High Quality dataset (ii) 240,000 chest X-rays from MIMIC III and (iii) a combined collection of 5 brain MRI datasets with 7,329 scans. Across all three datasets and without any dataset-specific hyperparameter tuning, our simple approach yields performance competitive with current task-specific state-of-the-art methods on super-resolution and in-painting, while being more generalisable and without requiring any training. Our source code and pre-trained models are available online: https://razvanmarinescu.github.io/brgm/.
△ Less
Submitted 9 December, 2021; v1 submitted 8 December, 2020;
originally announced December 2020.
-
Modelling the Neuroanatomical Progression of Alzheimer's Disease and Posterior Cortical Atrophy
Authors:
Razvan V. Marinescu
Abstract:
In order to find effective treatments for Alzheimer's disease (AD), we need to identify subjects at risk of AD as early as possible. To this end, recently developed disease progression models can be used to perform early diagnosis, as well as predict the subjects' disease stages and future evolution. However, these models have not yet been applied to rare neurodegenerative diseases, are not suitab…
▽ More
In order to find effective treatments for Alzheimer's disease (AD), we need to identify subjects at risk of AD as early as possible. To this end, recently developed disease progression models can be used to perform early diagnosis, as well as predict the subjects' disease stages and future evolution. However, these models have not yet been applied to rare neurodegenerative diseases, are not suitable to understand the complex dynamics of biomarkers, work only on large multimodal datasets, and their predictive performance has not been objectively validated. In this work I developed novel models of disease progression and applied them to estimate the progression of Alzheimer's disease and Posterior Cortical atrophy, a rare neurodegenerative syndrome causing visual deficits. My first contribution is a study on the progression of Posterior Cortical Atrophy, using models already developed: the Event-based Model (EBM) and the Differential Equation Model (DEM). My second contribution is the development of DIVE, a novel spatio-temporal model of disease progression that estimates fine-grained spatial patterns of pathology, potentially enabling us to understand complex disease mechanisms relating to pathology propagation along brain networks. My third contribution is the development of Disease Knowledge Transfer (DKT), a novel disease progression model that estimates the multimodal progression of rare neurodegenerative diseases from limited, unimodal datasets, by transferring information from larger, multimodal datasets of typical neurodegenerative diseases. My fourth contribution is the development of novel extensions for the EBM and the DEM, and the development of novel measures for performance evaluation of such models. My last contribution is the organization of the TADPOLE challenge, a competition which aims to identify algorithms and features that best predict the evolution of AD.
△ Less
Submitted 29 February, 2020;
originally announced March 2020.
-
The Alzheimer's Disease Prediction Of Longitudinal Evolution (TADPOLE) Challenge: Results after 1 Year Follow-up
Authors:
Razvan V. Marinescu,
Neil P. Oxtoby,
Alexandra L. Young,
Esther E. Bron,
Arthur W. Toga,
Michael W. Weiner,
Frederik Barkhof,
Nick C. Fox,
Arman Eshaghi,
Tina Toni,
Marcin Salaterski,
Veronika Lunina,
Manon Ansart,
Stanley Durrleman,
Pascal Lu,
Samuel Iddi,
Dan Li,
Wesley K. Thompson,
Michael C. Donohue,
Aviv Nahon,
Yarden Levy,
Dan Halbersberg,
Mariya Cohen,
Huiling Liao,
Tengfei Li
, et al. (71 additional authors not shown)
Abstract:
We present the findings of "The Alzheimer's Disease Prediction Of Longitudinal Evolution" (TADPOLE) Challenge, which compared the performance of 92 algorithms from 33 international teams at predicting the future trajectory of 219 individuals at risk of Alzheimer's disease. Challenge participants were required to make a prediction, for each month of a 5-year future time period, of three key outcome…
▽ More
We present the findings of "The Alzheimer's Disease Prediction Of Longitudinal Evolution" (TADPOLE) Challenge, which compared the performance of 92 algorithms from 33 international teams at predicting the future trajectory of 219 individuals at risk of Alzheimer's disease. Challenge participants were required to make a prediction, for each month of a 5-year future time period, of three key outcomes: clinical diagnosis, Alzheimer's Disease Assessment Scale Cognitive Subdomain (ADAS-Cog13), and total volume of the ventricles. The methods used by challenge participants included multivariate linear regression, machine learning methods such as support vector machines and deep neural networks, as well as disease progression models. No single submission was best at predicting all three outcomes. For clinical diagnosis and ventricle volume prediction, the best algorithms strongly outperform simple baselines in predictive ability. However, for ADAS-Cog13 no single submitted prediction method was significantly better than random guesswork. Two ensemble methods based on taking the mean and median over all predictions, obtained top scores on almost all tasks. Better than average performance at diagnosis prediction was generally associated with the additional inclusion of features from cerebrospinal fluid (CSF) samples and diffusion tensor imaging (DTI). On the other hand, better performance at ventricle volume prediction was associated with inclusion of summary statistics, such as the slope or maxima/minima of biomarkers. TADPOLE's unique results suggest that current prediction algorithms provide sufficient accuracy to exploit biomarkers related to clinical diagnosis and ventricle volume, for cohort refinement in clinical trials for Alzheimer's disease. However, results call into question the usage of cognitive test scores for patient selection and as a primary endpoint in clinical trials.
△ Less
Submitted 27 December, 2021; v1 submitted 9 February, 2020;
originally announced February 2020.
-
TADPOLE Challenge: Accurate Alzheimer's disease prediction through crowdsourced forecasting of future data
Authors:
Razvan V. Marinescu,
Neil P. Oxtoby,
Alexandra L. Young,
Esther E. Bron,
Arthur W. Toga,
Michael W. Weiner,
Frederik Barkhof,
Nick C. Fox,
Polina Golland,
Stefan Klein,
Daniel C. Alexander
Abstract:
The TADPOLE Challenge compares the performance of algorithms at predicting the future evolution of individuals at risk of Alzheimer's disease. TADPOLE Challenge participants train their models and algorithms on historical data from the Alzheimer's Disease Neuroimaging Initiative (ADNI) study. Participants are then required to make forecasts of three key outcomes for ADNI-3 rollover participants: c…
▽ More
The TADPOLE Challenge compares the performance of algorithms at predicting the future evolution of individuals at risk of Alzheimer's disease. TADPOLE Challenge participants train their models and algorithms on historical data from the Alzheimer's Disease Neuroimaging Initiative (ADNI) study. Participants are then required to make forecasts of three key outcomes for ADNI-3 rollover participants: clinical diagnosis, ADAS-Cog 13, and total volume of the ventricles -- which are then compared with future measurements. Strong points of the challenge are that the test data did not exist at the time of forecasting (it was acquired afterwards), and that it focuses on the challenging problem of cohort selection for clinical trials by identifying fast progressors. The submission phase of TADPOLE was open until 15 November 2017; since then data has been acquired until April 2019 from 219 subjects with 223 clinical visits and 150 Magnetic Resonance Imaging (MRI) scans, which was used for the evaluation of the participants' predictions. Thirty-three teams participated with a total of 92 submissions. No single submission was best at predicting all three outcomes. For diagnosis prediction, the best forecast (team Frog), which was based on gradient boosting, obtained a multiclass area under the receiver-operating curve (MAUC) of 0.931, while for ventricle prediction the best forecast (team EMC1), which was based on disease progression modelling and spline regression, obtained mean absolute error of 0.41% of total intracranial volume (ICV). For ADAS-Cog 13, no forecast was considerably better than the benchmark mixed effects model (BenchmarkME), provided to participants before the submission deadline. Further analysis can help understand which input features and algorithms are most suitable for Alzheimer's disease prediction and for aiding patient stratification in clinical trials.
△ Less
Submitted 23 January, 2020;
originally announced January 2020.
-
BrainPainter: A software for the visualisation of brain structures, biomarkers and associated pathological processes
Authors:
Razvan V. Marinescu,
Arman Eshaghi,
Daniel C. Alexander,
Polina Golland
Abstract:
We present BrainPainter, a software that automatically generates images of highlighted brain structures given a list of numbers corresponding to the output colours of each region. Compared to existing visualisation software (i.e. Freesurfer, SPM, 3D Slicer), BrainPainter has three key advantages: (1) it does not require the input data to be in a specialised format, allowing BrainPainter to be used…
▽ More
We present BrainPainter, a software that automatically generates images of highlighted brain structures given a list of numbers corresponding to the output colours of each region. Compared to existing visualisation software (i.e. Freesurfer, SPM, 3D Slicer), BrainPainter has three key advantages: (1) it does not require the input data to be in a specialised format, allowing BrainPainter to be used in combination with any neuroimaging analysis tools, (2) it can visualise both cortical and subcortical structures and (3) it can be used to generate movies showing dynamic processes, e.g. propagation of pathology on the brain. We highlight three use cases where BrainPainter was used in existing neuroimaging studies: (1) visualisation of the degree of atrophy through interpolation along a user-defined gradient of colours, (2) visualisation of the progression of pathology in Alzheimer's disease as well as (3) visualisation of pathology in subcortical regions in Huntington's disease. Moreover, through the design of BrainPainter we demonstrate the possibility of using a powerful 3D computer graphics engine such as Blender to generate brain visualisations for the neuroscience community. Blender's capabilities, e.g. particle simulations, motion graphics, UV unwrap**, raster graphics editing, raytracing and illumination effects, open a wealth of possibilities for brain visualisation not available in current neuroimaging software. BrainPainter is customisable, easy to use, and can run straight from the web browser: https://brainpainter.csail.mit.edu , as well as from source-code packaged in a docker container: https://github.com/mrazvan22/brain-coloring . It can be used to visualise biomarker data from any brain imaging modality, or simply to highlight a particular brain structure for e.g. anatomy courses.
△ Less
Submitted 22 August, 2019; v1 submitted 21 May, 2019;
originally announced May 2019.
-
DIVE: A spatiotemporal progression model of brain pathology in neurodegenerative disorders
Authors:
Razvan V. Marinescu,
Arman Eshaghi,
Marco Lorenzi,
Alexandra L. Young,
Neil P. Oxtoby,
Sara Garbarino,
Sebastian J. Crutch,
Daniel C. Alexander
Abstract:
Here we present DIVE: Data-driven Inference of Vertexwise Evolution. DIVE is an image-based disease progression model with single-vertex resolution, designed to reconstruct long-term patterns of brain pathology from short-term longitudinal data sets. DIVE clusters vertex-wise biomarker measurements on the cortical surface that have similar temporal dynamics across a patient population, and concurr…
▽ More
Here we present DIVE: Data-driven Inference of Vertexwise Evolution. DIVE is an image-based disease progression model with single-vertex resolution, designed to reconstruct long-term patterns of brain pathology from short-term longitudinal data sets. DIVE clusters vertex-wise biomarker measurements on the cortical surface that have similar temporal dynamics across a patient population, and concurrently estimates an average trajectory of vertex measurements in each cluster. DIVE uniquely outputs a parcellation of the cortex into areas with common progression patterns, leading to a new signature for individual diseases. DIVE further estimates the disease stage and progression speed for every visit of every subject, potentially enhancing stratification for clinical trials or management. On simulated data, DIVE can recover ground truth clusters and their underlying trajectory, provided the average trajectories are sufficiently different between clusters. We demonstrate DIVE on data from two cohorts: the Alzheimer's Disease Neuroimaging Initiative (ADNI) and the Dementia Research Centre (DRC), UK, containing patients with Posterior Cortical Atrophy (PCA) as well as typical Alzheimer's disease (tAD). DIVE finds similar spatial patterns of atrophy for tAD subjects in the two independent datasets (ADNI and DRC), and further reveals distinct patterns of pathology in different diseases (tAD vs PCA) and for distinct types of biomarker data: cortical thickness from Magnetic Resonance Imaging (MRI) vs amyloid load from Positron Emission Tomography (PET). Finally, DIVE can be used to estimate a fine-grained spatial distribution of pathology in the brain using any kind of voxelwise or vertexwise measures including Jacobian compression maps, fractional anisotropy (FA) maps from diffusion imaging or other PET measures. DIVE source code is available online: https://github.com/mrazvan22/dive
△ Less
Submitted 11 January, 2019;
originally announced January 2019.
-
Disease Knowledge Transfer across Neurodegenerative Diseases
Authors:
Razvan V. Marinescu,
Marco Lorenzi,
Stefano B. Blumberg,
Alexandra L. Young,
Pere P. Morell,
Neil P. Oxtoby,
Arman Eshaghi,
Keir X. Yong,
Sebastian J. Crutch,
Polina Golland,
Daniel C. Alexander
Abstract:
We introduce Disease Knowledge Transfer (DKT), a novel technique for transferring biomarker information between related neurodegenerative diseases. DKT infers robust multimodal biomarker trajectories in rare neurodegenerative diseases even when only limited, unimodal data is available, by transferring information from larger multimodal datasets from common neurodegenerative diseases. DKT is a join…
▽ More
We introduce Disease Knowledge Transfer (DKT), a novel technique for transferring biomarker information between related neurodegenerative diseases. DKT infers robust multimodal biomarker trajectories in rare neurodegenerative diseases even when only limited, unimodal data is available, by transferring information from larger multimodal datasets from common neurodegenerative diseases. DKT is a joint-disease generative model of biomarker progressions, which exploits biomarker relationships that are shared across diseases. Our proposed method allows, for the first time, the estimation of plausible, multimodal biomarker trajectories in Posterior Cortical Atrophy (PCA), a rare neurodegenerative disease where only unimodal MRI data is available. For this we train DKT on a combined dataset containing subjects with two distinct diseases and sizes of data available: 1) a larger, multimodal typical AD (tAD) dataset from the TADPOLE Challenge, and 2) a smaller unimodal Posterior Cortical Atrophy (PCA) dataset from the Dementia Research Centre (DRC), for which only a limited number of Magnetic Resonance Imaging (MRI) scans are available. Although validation is challenging due to lack of data in PCA, we validate DKT on synthetic data and two patient datasets (TADPOLE and PCA cohorts), showing it can estimate the ground truth parameters in the simulation and predict unseen biomarkers on the two patient datasets. While we demonstrated DKT on Alzheimer's variants, we note DKT is generalisable to other forms of related neurodegenerative diseases. Source code for DKT is available online: https://github.com/mrazvan22/dkt.
△ Less
Submitted 29 July, 2019; v1 submitted 11 January, 2019;
originally announced January 2019.
-
TADPOLE Challenge: Prediction of Longitudinal Evolution in Alzheimer's Disease
Authors:
Razvan V. Marinescu,
Neil P. Oxtoby,
Alexandra L. Young,
Esther E. Bron,
Arthur W. Toga,
Michael W. Weiner,
Frederik Barkhof,
Nick C. Fox,
Stefan Klein,
Daniel C. Alexander,
the EuroPOND Consortium
Abstract:
The Alzheimer's Disease Prediction Of Longitudinal Evolution (TADPOLE) Challenge compares the performance of algorithms at predicting future evolution of individuals at risk of Alzheimer's disease. TADPOLE Challenge participants train their models and algorithms on historical data from the Alzheimer's Disease Neuroimaging Initiative (ADNI) study or any other datasets to which they have access. Par…
▽ More
The Alzheimer's Disease Prediction Of Longitudinal Evolution (TADPOLE) Challenge compares the performance of algorithms at predicting future evolution of individuals at risk of Alzheimer's disease. TADPOLE Challenge participants train their models and algorithms on historical data from the Alzheimer's Disease Neuroimaging Initiative (ADNI) study or any other datasets to which they have access. Participants are then required to make monthly forecasts over a period of 5 years from January 2018, of three key outcomes for ADNI-3 rollover participants: clinical diagnosis, Alzheimer's Disease Assessment Scale Cognitive Subdomain (ADAS-Cog13), and total volume of the ventricles. These individual forecasts are later compared with the corresponding future measurements in ADNI-3 (obtained after the TADPOLE submission deadline). The first submission phase of TADPOLE was open for prize-eligible submissions between 15 June and 15 November 2017. The submission system remains open via the website: https://tadpole.grand-challenge.org, although since 15 November 2017 submissions are not eligible for the first round of prizes. This paper describes the design of the TADPOLE Challenge.
△ Less
Submitted 30 August, 2018; v1 submitted 10 May, 2018;
originally announced May 2018.
